• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮质类固醇滴眼剂的滴注加重了接种棘阿米巴和细菌的兔角膜中棘阿米巴角膜炎的发展。

Corticosteroid eye drop instillation aggravates the development of Acanthamoeba keratitis in rabbit corneas inoculated with Acanthamoeba and bacteria.

机构信息

Department of Ophthalmology, Tokyo Medical University, Shinjuku City, Japan.

Department of Microbiology, Tokyo Medical University, Shinjuku City, Japan.

出版信息

Sci Rep. 2019 Sep 6;9(1):12821. doi: 10.1038/s41598-019-49128-7.

DOI:10.1038/s41598-019-49128-7
PMID:31492880
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6731293/
Abstract

The role of topical corticosteroids in management of Acanthamoeba keratitis (AK) remains controversial. Using a rabbit AK model, we investigated whether corticosteroid use is a risk factor of AK. Acanthamoeba (1 × 10/ml) was incubated with two densities of P. aeruginosa (PA; high-PA: 1 × 10/ml, low-PA: 3 × 10/ml) before corneal inoculation. Rabbit corneas were inoculated with Acanthamoeba alone or Acanthamoeba plus PA and administered levofloxacin and betamethasone sodium phosphate (BSP) eye drops for 5 or 7 days. Infected rabbit eyes were evaluated for clinical score and Acanthamoeba by histological examination. Acanthamoeba alone and BSP treatment did not produce keratitis. Corneas inoculated with Acanthamoeba plus low-PA treated immediately with levofloxacin and BSP remained clear with few infiltrates. Corneas inoculated with Acanthamoeba plus low-PA treated with levofloxacin immediately and BSP 12 h later developed severe keratitis. Corneas inoculated with Acanthamoeba plus high-PA treated immediately with levofloxacin and BSP also developed severe keratitis. Acanthamoebae were detected by PAS staining in corneas inoculated with Acanthamoeba plus high-PA treated with levofloxacin and BSP. Topical corticosteroids have the potential to aggravate AK when cornea is infected by Acanthamoeba with a critical number of bacteria or when corticosteroids are given after infection has established by Acanthamoeba with small number of bacteria.

摘要

局部皮质类固醇在棘阿米巴角膜炎(AK)治疗中的作用仍存在争议。我们使用兔 AK 模型,研究皮质类固醇的使用是否是 AK 的一个危险因素。将棘阿米巴(1×10/ml)与两种密度的铜绿假单胞菌(PA;高 PA:1×10/ml,低 PA:3×10/ml)孵育后,进行角膜接种。兔角膜单独接种棘阿米巴或棘阿米巴加 PA,并用左氧氟沙星和磷酸倍他米松钠(BSP)滴眼剂治疗 5 或 7 天。用临床评分和组织学检查评估感染兔眼的棘阿米巴情况。单独的棘阿米巴和 BSP 治疗不会引起角膜炎。立即用左氧氟沙星和 BSP 治疗接种低 PA 的棘阿米巴的角膜仍保持清晰,仅有少量浸润。立即用左氧氟沙星和 BSP 治疗接种低 PA 的棘阿米巴,然后 12 小时后用 BSP 治疗的角膜会发生严重的角膜炎。立即用左氧氟沙星和 BSP 治疗接种高 PA 的棘阿米巴的角膜也会发生严重的角膜炎。用 PAS 染色在接种高 PA 的棘阿米巴并用左氧氟沙星和 BSP 治疗的角膜中检测到棘阿米巴。当角膜被大量细菌感染的棘阿米巴或当小数量细菌的棘阿米巴感染后给予皮质类固醇时,局部皮质类固醇有加重 AK 的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdbf/6731293/45f7949e7a0e/41598_2019_49128_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdbf/6731293/cddd80263100/41598_2019_49128_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdbf/6731293/89ba1ff91374/41598_2019_49128_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdbf/6731293/09ecc9c8ee60/41598_2019_49128_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdbf/6731293/45f7949e7a0e/41598_2019_49128_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdbf/6731293/cddd80263100/41598_2019_49128_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdbf/6731293/89ba1ff91374/41598_2019_49128_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdbf/6731293/09ecc9c8ee60/41598_2019_49128_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdbf/6731293/45f7949e7a0e/41598_2019_49128_Fig4_HTML.jpg

相似文献

1
Corticosteroid eye drop instillation aggravates the development of Acanthamoeba keratitis in rabbit corneas inoculated with Acanthamoeba and bacteria.皮质类固醇滴眼剂的滴注加重了接种棘阿米巴和细菌的兔角膜中棘阿米巴角膜炎的发展。
Sci Rep. 2019 Sep 6;9(1):12821. doi: 10.1038/s41598-019-49128-7.
2
Number of Bacteria and Time of Coincubation With Bacteria Required for the Development of Acanthamoeba Keratitis.棘阿米巴角膜炎发生所需的细菌数量及与细菌共培养的时间
Cornea. 2017 Mar;36(3):353-357. doi: 10.1097/ICO.0000000000001129.
3
Investigation of the Role of Bacteria in the Development of Acanthamoeba Keratitis.细菌在棘阿米巴角膜炎发病过程中的作用研究。
Cornea. 2015 Oct;34(10):1308-15. doi: 10.1097/ICO.0000000000000541.
4
Impact of topical corticosteroid pretreatment on susceptibility of the injured murine cornea to Pseudomonas aeruginosa colonization and infection.局部皮质类固醇预处理对小鼠角膜损伤后对铜绿假单胞菌定植和感染易感性的影响。
Exp Eye Res. 2019 Feb;179:1-7. doi: 10.1016/j.exer.2018.10.010. Epub 2018 Oct 19.
5
The role of naturally acquired intracellular Pseudomonas aeruginosa in the development of Acanthamoeba keratitis in an animal model.在动物模型中,天然获得的细胞内铜绿假单胞菌在棘阿米巴角膜炎发展中的作用。
PLoS Negl Trop Dis. 2024 Jan 2;18(1):e0011878. doi: 10.1371/journal.pntd.0011878. eCollection 2024 Jan.
6
In vivo challenging of polymyxins and levofloxacin eye drop against multidrug-resistant Pseudomonas aeruginosa keratitis.多粘菌素和左氧氟沙星滴眼液对多重耐药铜绿假单胞菌性角膜炎的体内挑战试验
J Infect Chemother. 2014 Jun;20(6):343-9. doi: 10.1016/j.jiac.2013.10.015. Epub 2013 Dec 11.
7
Two Different Concentrations of Topical Levofloxacin for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Keratitis.两种不同浓度的局部用左氧氟沙星治疗耐多药铜绿假单胞菌角膜炎
J Ocul Pharmacol Ther. 2015 Dec;31(10):636-41. doi: 10.1089/jop.2015.0026. Epub 2015 Sep 8.
8
In vitro transcorneal penetration of metronidazole and its potential use as adjunct therapy in Acanthamoeba keratitis.甲硝唑的体外角膜透入及其作为棘阿米巴角膜炎辅助治疗的潜在用途。
Cornea. 2004 May;23(4):386-9. doi: 10.1097/00003226-200405000-00014.
9
Evaluation of voriconazole anti-Acanthamoeba polyphaga in vitro activity, rat cornea penetration and efficacy against experimental rat Acanthamoeba keratitis.评估伏立康唑抗噬阿米巴多形虫的体外活性、大鼠角膜穿透性和对实验性大鼠噬阿米巴角膜炎的疗效。
J Antimicrob Chemother. 2018 Jul 1;73(7):1895-1898. doi: 10.1093/jac/dky094.
10
Efficacy of Photodynamic Anti-Microbial Chemotherapy for Acanthamoeba Keratitis In Vivo.光动力抗微生物化疗治疗棘阿米巴角膜炎的体内疗效。
Lasers Surg Med. 2021 Jul;53(5):695-702. doi: 10.1002/lsm.23355. Epub 2020 Dec 8.

引用本文的文献

1
Glaucoma animal models in rabbits: State of the art and perspectives-A review.兔青光眼动物模型:现状与展望——综述
Animal Model Exp Med. 2025 Mar;8(3):429-440. doi: 10.1002/ame2.12565. Epub 2025 Feb 6.
2
Development of an Ex Vivo Porcine Eye Model for Exploring the Pathogenicity of .用于探索……致病性的离体猪眼模型的建立
Microorganisms. 2024 Jun 6;12(6):1161. doi: 10.3390/microorganisms12061161.
3
Novel Drug Screening Assay for and the Anti-Amoebic Effect of Carbonic Anhydrase Inhibitors.新型药物筛选检测方法研究 和 碳酸酐酶抑制剂的抗阿米巴作用。

本文引用的文献

1
Number of Bacteria and Time of Coincubation With Bacteria Required for the Development of Acanthamoeba Keratitis.棘阿米巴角膜炎发生所需的细菌数量及与细菌共培养的时间
Cornea. 2017 Mar;36(3):353-357. doi: 10.1097/ICO.0000000000001129.
2
Investigation of the Role of Bacteria in the Development of Acanthamoeba Keratitis.细菌在棘阿米巴角膜炎发病过程中的作用研究。
Cornea. 2015 Oct;34(10):1308-15. doi: 10.1097/ICO.0000000000000541.
3
The impact of topical corticosteroid use before diagnosis on the outcome of Acanthamoeba keratitis.
J Med Chem. 2024 Jan 11;67(1):152-164. doi: 10.1021/acs.jmedchem.3c01020. Epub 2023 Dec 27.
4
New Frontiers in Keratitis Diagnosis and Management.角膜炎诊断与治疗新前沿
Biology (Basel). 2023 Dec 5;12(12):1489. doi: 10.3390/biology12121489.
5
Steroids in the Management of Infectious Keratitis.类固醇在感染性角膜炎治疗中的应用。
Cornea. 2023 Nov 1;42(11):1333-1339. doi: 10.1097/ICO.0000000000003340. Epub 2023 Jul 4.
6
Topical Sustained Delivery of Miltefosine Via Drug-Eluting Contact Lenses to Treat Acanthamoeba Keratitis.通过药物洗脱隐形眼镜局部持续递送米替福新治疗棘阿米巴角膜炎。
Pharmaceutics. 2022 Dec 8;14(12):2750. doi: 10.3390/pharmaceutics14122750.
7
Stimulation of excystment by enzyme treatment and consequences on trophozoite growth.酶处理对脱囊的刺激作用及其对滋养体生长的影响。
Front Cell Dev Biol. 2022 Sep 12;10:982897. doi: 10.3389/fcell.2022.982897. eCollection 2022.
8
Orthokeratology lens-related keratitis: case report and analytical review.角膜塑形镜相关角膜炎:病例报告与分析综述。
J Int Med Res. 2021 Mar;49(3):3000605211000985. doi: 10.1177/03000605211000985.
9
Drug Discovery against Infections: Present Knowledge and Unmet Needs.抗感染药物研发:当前认知与未满足的需求
Pathogens. 2020 May 22;9(5):405. doi: 10.3390/pathogens9050405.
诊断前局部皮质类固醇使用对棘阿米巴角膜炎结局的影响。
Ophthalmology. 2014 Jul;121(7):1383-8. doi: 10.1016/j.ophtha.2014.01.031. Epub 2014 Mar 14.
4
Assessment of real-time polymerase chain reaction detection of Acanthamoeba and prognosis determinants of Acanthamoeba keratitis.实时聚合酶链反应检测棘阿米巴及棘阿米巴角膜炎预后因素评估。
Ophthalmology. 2012 Jun;119(6):1111-9. doi: 10.1016/j.ophtha.2011.12.023. Epub 2012 Mar 3.
5
Detection of bacterial endosymbionts in clinical acanthamoeba isolates.临床棘阿米巴分离株中细菌内共生体的检测。
Ophthalmology. 2010 Mar;117(3):445-52, 452.e1-3. doi: 10.1016/j.ophtha.2009.08.033. Epub 2010 Jan 19.
6
Concurrent acanthamoeba and Fusarium keratitis with silicone hydrogel contact lens use.使用硅水凝胶隐形眼镜并发棘阿米巴和镰刀菌性角膜炎。
Cornea. 2010 Feb;29(2):210-3. doi: 10.1097/ICO.0b013e3181a1648b.
7
Polymicrobial keratitis: Acanthamoeba and infectious crystalline keratopathy.混合性角膜炎:棘阿米巴与感染性结晶状角膜病变。
Am J Ophthalmol. 2009 Jul;148(1):13-9.e2. doi: 10.1016/j.ajo.2009.01.020. Epub 2009 Mar 27.
8
Clinical and histologic evaluations of experimental Acanthamoeba keratitis.实验性棘阿米巴角膜炎的临床与组织学评估
Parasitol Res. 2007 Nov;101(6):1621-5. doi: 10.1007/s00436-007-0704-7. Epub 2007 Aug 14.
9
Acanthamoeba keratitis.棘阿米巴角膜炎
Int Ophthalmol Clin. 2007 Spring;47(2):33-46. doi: 10.1097/IIO.0b013e318036bcf4.
10
Acanthamoeba: biology and increasing importance in human health.棘阿米巴:生物学特性及其在人类健康中日益重要的地位
FEMS Microbiol Rev. 2006 Jul;30(4):564-95. doi: 10.1111/j.1574-6976.2006.00023.x.